Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Ultrasound Assessment of Lumbopelvic Muscles in Men With Chronic Low Back Pain

10. November 2026 aktualisiert von: Buse Sert, Medipol University

Ultrasonographic Evaluation of the Pelvic Floor and Lumbopelvic Stabilizer Muscles in Men With Chronic Nonspecific Low Back Pain

This study aims to evaluate the pelvic floor and lumbopelvic stabilizer muscles (transversus abdominis, internal oblique, and lumbar multifidus) using ultrasonography in men with chronic nonspecific low back pain. Muscle morphology and activation will be assessed at rest and during different functional tasks to investigate potential alterations in muscle coordination and lumbopelvic stability. The findings may contribute to a better understanding of neuromuscular dysfunction and guide rehabilitation strategies.

Studienübersicht

Status

Noch keine Rekrutierung

Detaillierte Beschreibung

Low back pain is a major musculoskeletal health problem with a high lifetime prevalence and is one of the leading causes of disability worldwide (1). In most cases, no specific pathological cause can be identified, and the condition is classified as nonspecific low back pain (2). When pain persists for more than three months, it is defined as chronic nonspecific low back pain, which negatively affects individuals' functional capacity, quality of life, and work participation (3). Multiple biomechanical, neuromuscular, psychosocial, and behavioral factors are thought to contribute to the development and persistence of chronic nonspecific low back pain (3).

In recent years, the concepts of lumbopelvic stability and motor control have gained increasing attention in explaining the underlying mechanisms of chronic low back pain. Lumbopelvic stabilization is a dynamic system resulting from the coordinated interaction of the spine, pelvis, and surrounding soft tissues through neuromuscular control. This system depends not only on passive structures but also on active muscular control and central nervous system integration (4, 5). Within this functional system, the transversus abdominis, internal oblique, lumbar multifidus, diaphragm, and pelvic floor muscles are considered key stabilizers. Rather than functioning independently, these muscles work synchronously through co-activation to maintain dynamic spinal stability. Therefore, dysfunction in any of these muscle groups may affect not only the individual muscle but also the overall coordination of the lumbopelvic stabilization system (6).

Delayed activation, reduced muscle thickness, atrophy, and impaired motor control of the transversus abdominis and lumbar multifidus muscles have been reported in individuals with chronic nonspecific low back pain (7, 8). Furthermore, recent studies have highlighted that the pelvic floor muscles play an important role not only in continence but also in maintaining lumbopelvic stability (6, 9). The pelvic floor muscles work in coordination with the transversus abdominis, multifidus, and diaphragm to regulate intra-abdominal pressure and contribute to spinal stabilization mechanisms (10). Consequently, impaired pelvic floor muscle function has been suggested to contribute to inadequate load transfer, altered motor control, and pain in the lumbopelvic region.

Although electromyography is widely used to assess muscle function, rehabilitative ultrasonography has emerged as a reliable, valid, and noninvasive method for examining muscle morphology and activation characteristics (11, 12). Ultrasonography enables real-time assessment of changes in muscle thickness and functional responses during muscle contraction. Ultrasonographic measurements have demonstrated high reliability, particularly in evaluating the activation of the transversus abdominis, internal oblique, lumbar multifidus, and pelvic floor muscles (13, 14).

In the existing literature, the abdominal muscles, multifidus, and pelvic floor muscles have generally been investigated separately in individuals with chronic nonspecific low back pain (6, 15). However, studies simultaneously evaluating the functional behavior of the transversus abdominis, internal oblique, lumbar multifidus, and pelvic floor muscles, which are essential components of the lumbopelvic stabilization system, remain limited (16). This limitation prevents a comprehensive understanding of functional coordination and potential co-activation impairments among these muscles (6). Moreover, research investigating the ultrasonographic activation characteristics of these muscles in men at rest, during the abdominal hollowing maneuver, and during voluntary pelvic floor muscle contraction is insufficient.

This study aims to address an important gap in the literature by comprehensively evaluating the transversus abdominis, internal oblique, lumbar multifidus, and pelvic floor muscles within the same individuals under different functional conditions. While previous studies have predominantly examined these muscle groups separately, research assessing their functional behavior during rest and various activation tasks remains limited. Furthermore, most studies investigating the relationship between pelvic floor function and lumbopelvic stability have focused on female populations, resulting in insufficient ultrasonographic data regarding these muscles in men. Therefore, this study aims to investigate the functional synergy of lumbopelvic muscles in men with chronic nonspecific low back pain and contribute to the understanding of motor control mechanisms and the development of targeted clinical rehabilitation strategies.

Studientyp

Beobachtungs

Einschreibung (Geschätzt)

40

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

  • Name: Büşra Yeşil, Asis. Prof. Dr.
  • Telefonnummer: +905452441047
  • E-Mail: dryesilll@gmail.com

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 65 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Männlich

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

The study population will consist of 40 male participants aged 18-65 years recruited at Medicana Bursa Hospital, Türkiye. Twenty participants with chronic nonspecific low back pain lasting at least three months will constitute the patient group, and 20 age-comparable healthy males without low back pain during the previous six months will constitute the control group. Pelvic floor and lumbopelvic stabilizer muscle function will be assessed using ultrasonography.

Beschreibung

Inclusion Criteria

Chronic Nonspecific Low Back Pain Group:

Male participants aged 18-65 years.

Chronic nonspecific low back pain lasting at least 3 months.

Body mass index (BMI) below 30 kg/m².

Ability to understand verbal instructions.

Willingness to participate voluntarily.

Provision of written informed consent.

Healthy Control Group:

Male participants aged 18-65 years.

No history of low back pain within the previous 6 months.

Body mass index (BMI) below 30 kg/m².

Ability to understand verbal instructions.

Willingness to participate voluntarily.

Provision of written informed consent.

Exclusion Criteria (Both Groups):

BMI ≥30 kg/m².

Regular sports exercise, core stabilization, Pilates, or pelvic floor exercises at least 3 days per week within the previous 6 months.

Employment involving heavy physical labor.

Specific spinal pathologies, including radiculopathy, spinal stenosis, spondylolisthesis, vertebral fracture, spinal infection, spinal tumor, or inflammatory spinal disease.

History of abdominal, pelvic, urinary tract, or lumbar surgery.

History of severe trauma affecting the lumbar region, pelvis, or lower extremities.

History of neurological disorders.

Urinary tract diseases, benign prostatic hyperplasia, urinary incontinence, or other urological conditions affecting pelvic floor function.

Umbilical or inguinal hernia.

Respiratory diseases associated with chronic cough.

Sacroiliac or hip joint pathologies.

Rheumatological, metabolic, or endocrine disorders affecting muscle function, such as diabetes mellitus or hypothyroidism.

History of malignancy.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Beobachtungsmodelle: CASE_CONTROL
  • Zeitperspektiven: CROSS_SECTIONAL

Kohorten und Interventionen

Gruppe / Kohorte
Chronic Nonspecific Low Back Pain Group

Twenty male participants aged 18-65 years with chronic nonspecific low back pain will undergo ultrasonographic assessment of pelvic floor and lumbopelvic stabilizer muscles.

Healthy Control Group

Twenty age-comparable healthy male participants aged 18-65 years will undergo the same ultrasonographic assessments.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Pelvic Floor Muscle Function Assessed by Ultrasonography
Zeitfenster: Baseline (single assessment session)

Pelvic floor muscle function will be assessed using transabdominal ultrasonography by measuring bladder base displacement (mm) during voluntary pelvic floor muscle contraction and abdominal hollowing.

Baseline (single assessment session)
Lumbopelvic Stabilizer Muscle Thickness and Contraction Ratios
Zeitfenster: Baseline (single assessment session)

ransversus abdominis, internal oblique, and lumbar multifidus muscle thickness (mm) will be measured using B-mode ultrasonography at rest, during abdominal hollowing, and during voluntary pelvic floor muscle contraction. Contraction ratios will be calculated as muscle thickness during activation divided by resting muscle thickness.

Baseline (single assessment session)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Functional Disability Assessed by the Oswestry Disability Index (ODI)
Zeitfenster: Baseline (single assessment session)

Functional disability related to low back pain will be assessed using the Oswestry Disability Index (ODI). The total score will be expressed as a percentage (0-100%), with higher scores indicating greater disability.

Baseline (single assessment session)
Pain Intensity Assessed by the Numeric Rating Scale (NRS)
Zeitfenster: Baseline (single assessment session)

Pain intensity will be assessed using an 11-point Numeric Rating Scale (0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Participants with chronic low back pain will report their average pain intensity during the previous week.

Baseline (single assessment session)
Health-Related Quality of Life Assessed by EQ-5D-5L
Zeitfenster: Baseline (single assessment session)

Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L), covering mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. General health status will also be assessed using the EQ VAS (0-100).

Baseline (single assessment session)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

10. November 2026

Primärer Abschluss (Geschätzt)

10. Mai 2027

Studienabschluss (Geschätzt)

10. Juli 2027

Studienanmeldedaten

Zuerst eingereicht

10. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

10. November 2026

Zuerst gepostet (Tatsächlich)

16. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

16. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

10. November 2026

Zuletzt verifiziert

1. September 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren